Frazier Capital is a leader in the valuation of intangible assets—those non-physical resources that often drive the majority of a company’s enterprise value. Unlike tangible assets, intangibles such as trademarks, patents, proprietary software, brand value, customer relationships, and goodwill require specialized analysis to quantify their economic contribution and market relevance. Our professionals apply recognized valuation methodologies, including the relief-from-royalty method, excess earnings method, and cost-to-recreate approach, always grounded in current market evidence and industry benchmarks.

​

Our experience spans diverse sectors—from biotech and technology startups with mission-critical IP, to consumer brands where reputation and customer loyalty define enterprise value. We have conducted valuations for purchase price allocations under ASC 805, impairment testing under ASC 350, licensing and transfer pricing, litigation support, and estate planning.

​

Clients rely on Frazier Capital when intangible value must be substantiated with precision and authority. Our reports have been cited in tax disputes, leveraged in licensing negotiations, and accepted in global transactions involving complex intellectual property portfolios. Whether the assignment involves valuing a pharmaceutical patent pending FDA approval, a brand’s global recognition, or proprietary algorithms powering a technology company, we bring the rigor, independence, and market insight necessary to capture the true worth of intangible assets in today’s competitive economy.